Philip R Judge BVSc MVS PG Cert Vet Stud MACVSc (Vet Emergency and Critical Care; Medicine of Dogs)
Introduction
Cutaneous paraneoplastic syndromes (CPSs) in cats are rare but clinically significant – as they often represent the first visible clue to an underlying malignancy. The comprehensive review from Guillen et al consolidates current knowledge on feline CPSs, and we’ve distilled the key clinical takeaways to help you recognise, investigate, and manage these challenging cases in practice.
Takeaway 1: Two Syndromes Dominate the Literature – Know Them Well
While several CPSs have been reported in cats, feline paraneoplastic alopecia (FPA) and thymoma-associated exfoliative dermatitis (ED) account for the vast majority of published cases. Familiarity with their classic presentations is essential.
Feline Paraneoplastic Alopecia
- Appearance: Rapidly progressive, symmetrical, non-pruritic alopecia affecting the ventrum, medial limbs, and perineum. The skin appears smooth, shiny, and thin – but not fragile. The dorsum is typically spared.
- Associated tumours: Most commonly pancreatic adenocarcinoma and biliary carcinoma; less frequently intestinal carcinoma, hepatocellular carcinoma, and neuroendocrine tumours.
- Key feature: Secondary Malassezia overgrowth is common, which may introduce pruritus, erythema, and crusting – potentially masking the underlying non-pruritic nature.
- Prognosis: Guarded to poor. Most cats with pancreatic or biliary carcinoma are euthanised within 2 months of presentation due to advanced metastatic disease at diagnosis.
Thymoma-Associated Exfoliative Dermatitis
- Appearance: Generalised scaling, erythema, and alopecia progressing to marked hyperkeratosis, crusting, and erosions. Typically affects head, neck, and trunk.
- Associated tumour: Thymic epithelial tumours (TETs). One reported case involved an ectopic TET located cervical to the thoracic inlet.
- Key feature: Skin histopathology reveals lymphocytic interface dermatitis with hydropic degeneration of basal keratinocytes – essentially an immune-mediated attack on the epidermis.
- Prognosis: Significantly better than FPA if the tumour is non-invasive and surgically resectable, with median survival around 2.5 years and documented resolution of skin lesions post-thymectomy.
Clinical pearl: If you see a middle-aged to older cat with generalised scaling or unexplained ventral alopecia, CPS belongs on your differential list.
Takeaway 2: Histopathology is Essential – But You Must Biopsy Smart
Skin biopsy is essential to differentiate CPS from primary dermatopathies, but the way you biopsy matters.
Key biopsy principles:
- Preserve crusts and scales: In thymoma-associated exfoliative dermatitis, most diagnostic changes are in the epidermis. Loss of surface material during sample preparation can render the biopsy non-diagnostic.
- Biopsy early: Biopsy before starting empirical therapy (steroids, antibiotics, antifungals) that may alter histological appearance.
- Sample multiple sites: Lesions may vary in severity, and some CPSs show patchy histological changes.
- Communicate with your pathologist: Provide a full clinical history and explicitly state your suspicion of CPS – as this guides special stains and interpretive focus.
Histological hallmarks to remember:
| Syndrome | Key histological findings |
|---|---|
| Exfoliative dermatitis | Lymphocytic interface dermatitis, hydropic degeneration of basal keratinocytes, pan-epidermal single cell necrosis, absent/atrophic sebaceous glands |
| Paraneoplastic alopecia | Marked follicular atrophy, miniaturisation/telogenisation of follicles, variable epidermal changes |
| Superficial necrolytic dermatitis | “Red, white and blue” pattern—parakeratosis (red), intracellular oedema (white), basal cell hyperplasia (blue) |
Clinical pearl: Changes in superficial necrolytic dermatitis may be more subtle in cats than dogs – so don’t rely on classic florid changes alone. If you suspect it, biopsy and image the abdomen.
Takeaway 3: Imaging is the Bridge Between Skin and Tumour
If you have biopsied and if CPS remains on the list, you must look for the tumour – even if the cat appears systemically well at presentation.
Approach by syndrome:
- For suspected ED: Thoracic imaging (radiographs or CT) to identify a cranial mediastinal mass. Remember: ectopic TET can occur cranial to the thoracic inlet – if chest is clear, consider extending your imaging field.
- For suspected FPA: Abdominal imaging (ultrasound or CT) to evaluate pancreas, liver, and biliary tract. These tumours are often small, multifocal, or metastatic at presentation – CT may outperform ultrasound for detection of small pancreatic or hepatic nodules.
- For suspected SND: Abdominal imaging to identify pancreatic or hepatic neuroendocrine tumours. Consider advanced imaging (CT) for surgical planning if a solitary lesion is identified.
Additional considerations:
- Flow cytometry of mediastinal mass aspirates: Helpful in dogs for differentiating TET from lymphoma, but less useful in cats due to high prevalence of CD4+/CD8+ T cells in feline mediastinal lymphoma.
- Immunohistochemistry: Anti-glucagon antibody staining supported the diagnosis in two feline SND cases; cytokeratin 7 and 20 helped confirm cholangiocarcinoma in one FPA case.
Clinical pearl: A normal thoracic radiograph doesn’t rule out TET-associated ED – consider CT or cervical ultrasound if suspicion remains high.
Takeaway 4: Treatment Success Hinges on Tumour Control – Not Skin-Directed Therapy
The skin lesions in CPS are driven by the tumour. Treating the skin alone will fail.
What works:
- Surgical resection: Offers the best chance of cutaneous remission. Documented in:
- TET-associated ED (complete/partial resolution post-thymectomy)
- FPA (one cat with solitary pancreatic tumour: alopecia resolved, recurred at metastasis 18 weeks later)
- Putative paraneoplastic pemphigus (resolution post-thymectomy plus immunosuppression)
- Radiotherapy: A promising alternative for non-resectable TETs due to inherent radiosensitivity. Impact on cutaneous signs unknown but worth considering.
What doesn’t work (alone):
- Corticosteroids: No improvement in ED or FPA cases treated with steroids alone. May temporarily palliate pruritus from secondary infections but doesn’t alter disease progression.
- Symptomatic therapy: Nutritional support, antifungals (itraconazole/ketoconazole for Malassezia), antibiotics, and topical therapy may improve quality of life short-term but won’t resolve the underlying process.
Emerging options:
- Toceranib phosphate: Reported in cats with pancreatic carcinoma; benefit in FPA unknown but worth considering where surgery isn’t possible.
- Amino acid infusions: Used successfully in canine SND; not yet reported in feline tumour-associated SND but theoretically plausible given shared pathophysiology.
Clinical pearl: If you can’t find or can’t treat the tumour, be honest with owners—prognosis is guarded and skin lesions will persist or progress.
Takeaway 5: Rarer Syndromes Exist – Don’t Miss Them
While FPA and ED dominate, other CPSs have been reported and may present diagnostic challenges.
Skin fragility syndrome
- Presentation: Extremely fragile, thin skin that tears easily; extensive ulcerations, poor healing.
- Associated tumours: Cholangiocarcinoma, follicular lymphoma.
- Note: Clinically indistinguishable from fragility secondary to hyperadrenocorticism or cachexia—investigate thoroughly.
Superficial necrolytic dermatitis
- Presentation: Severe erythema, thick crusts, ulcers, fissures affecting paws, muzzle, periocular, perianal, and perigenital skin. Painful lesions, often with secondary infection.
- Associated tumours: Glucagonoma, hepatic neuroendocrine carcinoma, pancreatic carcinoma.
- Diagnostic aids: Elevated fasting plasma glucagon and hypoaminoacidaemia supportive (validated glucagon ELISA available for cats).
Paraneoplastic pemphigus
- Presentation: Extensive erosions/ulcers (one feline case involved caudal ventrum, axillae, pinnae. No mucosal involvement).
- Associated tumour: Thymoma (also had concurrent myasthenia gravis).
- Treatment: Surgical removal + immunosuppression (prednisolone, chlorambucil) led to long-term remission in the reported case.
Other reported associations:
- Multifocal non-inflammatory alopecia (TET)
- Cutaneous necrosis (follicular lymphoma)
- Lymphocytic mural folliculitis (pancreatic carcinoma. May represent early FPA)
Clinical pearl: If a cat presents with an unusual, progressive dermatosis and systemic signs (weight loss, lethargy, inappetence), think beyond the skin. The tumour may be hiding in plain sight.
Final Thoughts
CPSs in cats are under-recognised. The veterinary literature describes far fewer syndromes than human medicine, but this likely reflects under-diagnosis rather than true rarity. By maintaining a high index of suspicion, biopsy strategically, and imaging thoroughly, you may detect an occult malignancy earlier than would otherwise be possible.
Key red flags that should prompt CPS investigation:
- Older cat with new-onset dermatosis
- Atypical presentation or poor response to conventional therapy
- Concurrent systemic signs (even if mild)
- Histology showing interface dermatitis, follicular atrophy, or necrolytic changes
Early diagnosis won’t always change outcome—particularly for aggressive tumours like pancreatic carcinoma – but it provides owners with answers and, in some cases (notably TET-associated ED), offers a genuine chance of remission through surgical intervention.
Reference: Guillen A, Hendricks A, Verbrugghe A, Rocchigiani G, Espadale E. Cutaneous paraneoplastic syndromes in cats: a comparative clinical review. Journal of Feline Medicine and Surgery. 2026.
